Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-03-026630
Filing Date
2003-11-14
Accepted
2003-11-14 15:01:26
Documents
8
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a03-5105_110q.htm 10-Q 377146
3 EX-10.1 a03-5105_1ex10d1.htm EX-10.1 95482
4 EX-10.2 a03-5105_1ex10d2.htm EX-10.2 45984
5 EX-31.1 a03-5105_1ex31d1.htm EX-31.1 10123
6 EX-31.2 a03-5105_1ex31d2.htm EX-31.2 10153
7 EX-32.1 a03-5105_1ex32d1.htm EX-32.1 5253
8 EX-32.2 a03-5105_1ex32d2.htm EX-32.2 5259
9 GRAPHIC g51051baimage002.gif GRAPHIC 6156
  Complete submission text file 0001104659-03-026630.txt   557909
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12493 | Film No.: 031003635
SIC: 2836 Biological Products, (No Diagnostic Substances)